Details for New Drug Application (NDA): 018000
✉ Email this page to a colleague
The generic ingredient in BRICANYL is terbutaline sulfate. There are seven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the terbutaline sulfate profile page.
Summary for 018000
Tradename: | BRICANYL |
Applicant: | Sanofi Aventis Us |
Ingredient: | terbutaline sulfate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 018000
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | AEROSOL, METERED;INHALATION | Strength | 0.2MG/INH | ||||
Approval Date: | Mar 19, 1985 | TE: | RLD: | No |
Expired US Patents for NDA 018000
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sanofi Aventis Us | BRICANYL | terbutaline sulfate | AEROSOL, METERED;INHALATION | 018000-001 | Mar 19, 1985 | ⤷ Sign Up | ⤷ Sign Up |
Sanofi Aventis Us | BRICANYL | terbutaline sulfate | AEROSOL, METERED;INHALATION | 018000-001 | Mar 19, 1985 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription